We found that the antioxidant gallic acid inhibits aflatoxin formation in *A. flavus* in a dose-dependent manner: The mechanism was suggested as being through the FarB-mediated β-oxidation and CreA activity, with some contribution from the pentose phosphate pathway.

1. Introduction {#sec1-toxins-10-00270}
===============

*Aspergillus flavus* is not only a saprotrophic and plant pathogenic fungus but also an opportunistic human and animal pathogen \[[@B1-toxins-10-00270]\]. *A. flavus* is notorious for production of aflatoxins, which were discovered as the main cause of Turkey-X disease in the 1960s \[[@B2-toxins-10-00270]\]. Since then, substantial efforts have been directed toward understanding the complex mechanisms and the regulation network of aflatoxin biosynthesis.

Primary metabolism has a close link with secondary metabolite synthesis in fungi and, in the case of aflatoxin, several studies have shown that β-oxidation contributes to high levels of aflatoxin. Fatty acid β-oxidation in both the peroxisome and mitochondria has a fundamental contribution to toxin production, such as the polyketides, aflatoxin, and sterigmatocystin \[[@B3-toxins-10-00270]\]. Reverberi et al. treated *A. flavus* with bezafibrate, an inducer of peroxisomal β-oxidation in mammals, and stimulated aflatoxin production. They also introduced a P33 gene into *A. flavus* to induce peroxisome proliferation, which leads to an upregulation of lipid metabolism and higher content of intracellular reactive oxygen species (ROS), with increasing aflatoxin formation \[[@B4-toxins-10-00270]\]. The metabolomic studies also demonstrated that the lack of aflatoxin formation in a known aflatoxin inhibitory medium (peptone) was accompanied with suppressed fatty acid synthesis and reduced tricarboxylic acid (TCA) cycle intermediates, and increased pentose phosphate pathway products \[[@B5-toxins-10-00270]\]. The accumulating NADPH pool, derived primarily from the pentose phosphate pathway, was suggested to suppress aflatoxin synthesis by directing the acyl-CoA into lipid synthesis, rather than polyketide biosynthesis \[[@B6-toxins-10-00270],[@B7-toxins-10-00270]\].

In addition to a requirement for adequate acyl-CoA pools to synthesize aflatoxin, several groups have proposed that oxidative stress is a prerequisite for aflatoxin biosynthesis in *Aspergillus parasiticus* \[[@B8-toxins-10-00270],[@B9-toxins-10-00270],[@B10-toxins-10-00270]\]. This observation is tied in with the hypothesis that aflatoxin is a secondary defense system protecting the fungus from excess ROS \[[@B11-toxins-10-00270]\]. Supporting these proposals are studies showing that compounds which altered oxidative stress in *A. flavus* or *A. parasiticus* also affected aflatoxin production. For example, the pro-oxidants cumene, hydroperoxide, and hydrogen peroxide promoted aflatoxin biosynthesis in *A. flavus* \[[@B4-toxins-10-00270]\], and epoxides stimulated aflatoxin formation by increasing the lipid peroxidation in *A. flavus* and *A. parasiticus* \[[@B12-toxins-10-00270]\]. Conversely, antioxidants, such as ethylene, alleviated the oxidative stress and changed the glutathione redox state in *A. flavus*, which resulted in inhibiting aflatoxin biosynthesis \[[@B13-toxins-10-00270]\]. *Lentinula edodes* β-glucan significantly reduced aflatoxin formation in *A. parasiticus* by stimulating antioxidant enzyme activity, and the activation of antioxidant response-related transcription factors, which correlated with a delay of aflatoxin genes expression \[[@B14-toxins-10-00270]\]. Piperine inhibited aflatoxin production in *A. flavus* concurrently with positive regulation of genes belonging to superoxide dismutase and catalase families, as well as genes encoding the basic leucine zipper (bZIP) transcription factors AtfA, AtfB, and Ap-1 \[[@B15-toxins-10-00270]\]. These bZIP transcription factors and MsnA are thought to participate in a regulatory network that mediates both the oxidative stress and aflatoxin pathways in *A. parasiticus* \[[@B11-toxins-10-00270]\].

Gallic acid (GA), a constituent in the pellicle of Tulare walnut, has shown potent inhibitory activity toward aflatoxin biosynthesis \[[@B16-toxins-10-00270]\], but the mechanism of GA inhibition of aflatoxin formation has not been studied. We present here our finding that GA significantly inhibited the expression of the *farB* gene, which controls the activity of peroxisomal fatty acid β-oxidation \[[@B17-toxins-10-00270]\], and of the carbon repression regulator encoding gene, *creA*, which has recently been found involved in aflatoxin synthesis \[[@B18-toxins-10-00270]\]. Simultaneously, the expression of almost all assigned genes in the aflatoxin biosynthesis cluster was significantly downregulated by 0.8% (*w*/*v*) GA treatment. Our work provides insights into cellular mechanisms underlying oxidative stress responses contributing to aflatoxin biosynthesis in *A. flavus*.

2. Results {#sec2-toxins-10-00270}
==========

2.1. Effect of GA on Aflatoxin Biosynthesis and Growth in A. flavus {#sec2dot1-toxins-10-00270}
-------------------------------------------------------------------

Treatment of *A. flavus* NRRL3357 spores with different concentrations (0, 0.2%, 0.5%, 0.8%, and 1%, *w*/*v*: Weight/volume) of GA showed that GA inhibited aflatoxin B~1~ synthesis in a dose-dependent manner ([Figure 1](#toxins-10-00270-f001){ref-type="fig"}). Aflatoxin B~1~ production was significantly inhibited when the GA concentration was 0.5% (*w*/*v*), and was totally inhibited with greater than 0.8% (*w*/*v*) GA in the medium. Aflatoxin reduction was positively correlated with a decrease in *A. flavus* colony diameter ([Figure 2](#toxins-10-00270-f002){ref-type="fig"}A,B), with the maximum inhibition rate of 24% in the 1% (*w*/*v*) treated samples at the 3rd-day cultivation ([Table S1](#app1-toxins-10-00270){ref-type="app"}). However, when *A. flavus* was inoculated into liquid PDB medium, mycelial mass increased in the 1% (*w*/*v*) GA treated samples compared with the untreated samples ([Figure 2](#toxins-10-00270-f002){ref-type="fig"}C).

A sample of 10^7^ spores was inoculated into 30 mL PDB with different concentration (0, 0.2%, 0.5%, 0.8%, 1%, *w*/*v*) of GA, cultured at 30 °C, 200 rpm. Next, 200 µL culture medium were taken out at 24 h, 48 h, and 72 h, respectively, for TLC analysis, AFB~1~: Aflatoxin B~1~ standard from Sigma. These were 0.2% GA: 0.2% (*w*/*v*) GA, 0.5% GA: 0.5% (*w*/*v*) GA, 0.8% GA: 0.8% (*w*/*v*) GA, 1% GA: 1% (*w*/*v*) GA. *w*/*v*: Weight/volume, such as 0.3 g GA add into 30 mL PDB medium will make a PDB+1% (*w*/*v*) GA.

2.2. Transcriptomic Profiles of A. flavus Responding to GA {#sec2dot2-toxins-10-00270}
----------------------------------------------------------

In order to gain insight into the mechanism by which GA inhibits aflatoxin synthesis, RNA was extracted from 24 h cultures treated with either 0.2% (*w*/*v*) GA (partly inhibits aflatoxin B~1~ formation) or 0.8% (*w*/*v*) GA (totally inhibits aflatoxin B~1~ formation) for RNA-Seq analysis. [Table S2](#app1-toxins-10-00270){ref-type="app"} summarizes the RNA-Seq data. The FPKM \[[@B19-toxins-10-00270]\] value had been applied to quantify the level of each genes' expression, and the count number of each gene from the three sequenced samples were analyzed by DEseq software \[[@B20-toxins-10-00270]\] for genes' different expression analysis. The genes with \|log2Ratio\| ≥ 1 and *q* \< 0.05 were considered as significantly differentially expressed and listed in [Table S3](#app1-toxins-10-00270){ref-type="app"}. In total, 535 genes were significantly differentially transcribed between 0.2% (*w*/*v*) GA treated and untreated *A. flavus* samples, and 2040 significantly differentially expressed genes were found in 0.8% (*w*/*v*) GA treated compared with untreated *A. flavus* samples ([Table 1](#toxins-10-00270-t001){ref-type="table"}). In addition, 361 shared genes were found in these two sets ([Figure 3](#toxins-10-00270-f003){ref-type="fig"}, [Table S3](#app1-toxins-10-00270){ref-type="app"}).

2.3. Effect of GA on the Expression of Genes in A. flavus Secondary Metabolism Clusters {#sec2dot3-toxins-10-00270}
---------------------------------------------------------------------------------------

There are 56 predicted secondary metabolism gene clusters in *A. flavus* \[[@B21-toxins-10-00270],[@B22-toxins-10-00270]\], most of which contain a gene encoding for a 'backbone' enzyme (e.g., PKS, NRPS, DMATs, terpene, etc) essential for their respective secondary metabolite biosynthesis \[[@B22-toxins-10-00270]\]. The effect of GA on the *A. flavus* 56 secondary metabolism clusters activity was analyzed based on the 'backbone' genes expression in our RNA-Seq data, and the data showed that there were 16 secondary metabolism clusters significantly affected by GA treatment ([Table S4](#app1-toxins-10-00270){ref-type="app"}). The cluster \#54, responsible for the aflatoxin biosynthesis, was one of these 16 clusters, and almost all the assigned genes (except the regulatory genes *aflR* and *aflS* \[[@B23-toxins-10-00270]\]) expression were significantly downregulated in the 0.8% (*w*/*v*) GA treated samples compared with the untreated samples ([Figure 4](#toxins-10-00270-f004){ref-type="fig"}, [Table S3](#app1-toxins-10-00270){ref-type="app"}). These data are consistent with the 0.8% (*w*/*v*) GA totally inhibiting aflatoxin formation in *A. flavus* ([Figure 1](#toxins-10-00270-f001){ref-type="fig"}).

2.4. Expression Changes of the Developmental Regulatory Genes and the Primary Metabolic Genes in A. flavus in Response to GA {#sec2dot4-toxins-10-00270}
----------------------------------------------------------------------------------------------------------------------------

Because the genes encoding aflatoxin transcription factors *aflR* and *aflS* were not significantly affected by GA ([Table S3](#app1-toxins-10-00270){ref-type="app"}), we next examined the RNA-seq for other clues as to why aflatoxin biosynthesis and gene expression were down regulated. We first looked at transcriptional regulators of aflatoxin. The Velvet Complex heterotrimer is a critical transcriptional complex required for secondary metabolism and fungal development in *Aspergillus* spp. \[[@B24-toxins-10-00270]\], including *A. flavus* \[[@B25-toxins-10-00270]\]. However, in our data, the expression of all three members, *veA, velB*, and *laeA* were not significantly different in the GA-treated *A. flavus* samples compared with the untreated *A. flavus* samples. We also observed that *nsdC* encoding a C~2~H~2~ zinc finger-type DNA-binding protein, which is required for normal sclerotia formation and aflatoxin biosynthesis in *A. flavus* \[[@B26-toxins-10-00270]\], was upregulated ([Table 2](#toxins-10-00270-t002){ref-type="table"}) and thus not a likely cause of loss of aflatoxin production by GA.

Carbon utilization pathways have also been associated with aflatoxin biosynthesis. In our RNA-Seq data, most of the putative genes responsible for the pentose phosphate pathway were upregulated by GA treatment, such as AFLA_086620, AFLA_080390, and AFLA_036840 ([Table 2](#toxins-10-00270-t002){ref-type="table"}) encoding proteins homologous to Zwf1, Sol3, and Gnd1 in *Candida albicans*, respectively \[[@B27-toxins-10-00270]\]. Pentose phosphate pathway activity has been linked to decreased aflatoxin synthesis in a previous study \[[@B5-toxins-10-00270]\] and thus supports a possible role of this pathway in gallic acid repression of aflatoxin production.

Fatty acids and β-oxidation have been largely shown to promote aflatoxin biosynthesis \[[@B3-toxins-10-00270],[@B28-toxins-10-00270]\]. The most striking finding from the RNA-seq data was the large number of peroxisome and fatty acid β-oxidation-related genes ([Table S5](#app1-toxins-10-00270){ref-type="app"}) which were significantly and primarily down regulated by GA treatment based on the GO analysis ([Table S6](#app1-toxins-10-00270){ref-type="app"}). These genes included the peroxisomal β-oxidation multifunctional enzyme encoding gene, *foxA* \[[@B29-toxins-10-00270]\], and acetyl-carnitine transferase encoding gene, *acuJ* \[[@B30-toxins-10-00270]\]. The fatty acid metabolism regulatory transcription factor gene, *farB* (AFLA_012010), was also downregulated. FarB has been reported as positively affecting aflatoxin biosynthesis in *A. flavus* via regulating the expression of the peroxisomal fatty acid β-oxidation-related genes *pexK*, *foxA*, and *acuJ* \[[@B17-toxins-10-00270]\].

Finally, we noted that the carbon catabolite repression gene, *creA* \[[@B31-toxins-10-00270]\], decreased with the increasing concentration of GA and was significantly downregulated in the 0.8% (*w*/*v*) GA-treated samples compared with the untreated samples ([Table 2](#toxins-10-00270-t002){ref-type="table"}). CreA regulates gene expression, either directly by binding to the consensus binding sites (5′-SYGGRG-3′) in the promoter of the target genes \[[@B32-toxins-10-00270]\], or through transcriptional cascades. This consensus binding site is found in 14 out of the 19 aflatoxin gene promoter regions ([Table 3](#toxins-10-00270-t003){ref-type="table"}), and because expression of these genes (except *aflR* and *aflS*) was significantly downregulated by GA treatment, it appeared likely that GA regulation of *creA* was also contributing to the reduction of aflatoxin synthesis. Indeed we found that all 19 assigned aflatoxin genes were significantly downregulated in two independent ∆*creA* mutants compared with wild type (WT) ([Figure 5](#toxins-10-00270-f005){ref-type="fig"}). These results were consistent with the loss of aflatoxin synthesis in the deletion of *creA* in another strain of *A. flavus*, CA14 \[[@B18-toxins-10-00270]\].

2.5. Effect of GA on Oxidative Stress Genes and the Antioxidant Enzymatic Activities {#sec2dot5-toxins-10-00270}
------------------------------------------------------------------------------------

In *A. flavus*, there are several oxidative stress-related transcription factors that mediate oxidative stress and aflatoxin formation, and among these AtfA, AtfB, Ap-1, and MsnA have been characterized \[[@B33-toxins-10-00270],[@B34-toxins-10-00270],[@B35-toxins-10-00270],[@B36-toxins-10-00270]\]. The expression of the genes encoding these transcription factors did not show significant difference in the GA-treated samples compared with the untreated samples. However, we found some of the enzymatic genes regulated by these transcription factors were differentially regulated, including the genes encoding the antioxidant enzymes catalase (AFLA_056170, AFLA_122110, and AFLA_090690) and superoxide dismutase (SOD, AFLA_099000, and AFLA_033420), which were slightly upregulated in the 0.8% (*w*/*v*) GA-treated samples compared with the untreated samples. Additionally, genes encoding the glutathione S-transferase and the thioredoxin system proteins presented significantly higher expression levels in the 0.8% (*w*/*v*) GA-treated samples compared with the untreated samples ([Table 4](#toxins-10-00270-t004){ref-type="table"}). Oxylipin synthesis is associated with oxidative processes and aflatoxin biosynthesis and, as shown in [Table 4](#toxins-10-00270-t004){ref-type="table"}, the *ppoC* gene encoding for oxylipin biosynthesis \[[@B37-toxins-10-00270]\] and the GPCRs genes *gprC*, *gprK*, and *gprM*---implicated in oxylipin perception \[[@B38-toxins-10-00270]\]---were significantly inhibited by at least one GA treatment.

To gain more information on this possible linkage of GA with oxidative processes, the activities of catalase and SOD and the level of Malondialdehyde (MDA, as a marker of lipid oxidation) were measured in the 0.2% (*w*/*v*) and 0.8% (*w*/*v*) GA-treated and untreated *A. flavus* samples with 24 h cultivation. Results, shown in [Figure 6](#toxins-10-00270-f006){ref-type="fig"}, demonstrated that the MDA content was decreased by GA treatment ([Figure 6](#toxins-10-00270-f006){ref-type="fig"}A), and the activities of catalase and SOD were also inhibited in the GA treated samples compared with the untreated samples ([Figure 6](#toxins-10-00270-f006){ref-type="fig"}B,C), despite a slight increase in gene expression. These results and the expression of the antioxidant genes indicate that GA may balance oxidative stress homeostasis in *A. flavus* via activating the glutathione- and thioredoxin-dependent antioxidant system, rather than through catalase and SOD activity.

3. Discussion {#sec3-toxins-10-00270}
=============

Upon finding that GA was effective in suppressing aflatoxin synthesis, Mahoney and Molyneux \[[@B16-toxins-10-00270]\] suggested the mechanism might be through GA control of the fatty acid synthases (*aflA*, *aflB*) or polyketide synthase (*aflC*) required for generation of norsolorinic acid, the first visible and stable intermediate in the aflatoxin synthesis pathway \[[@B23-toxins-10-00270]\], which accumulates in peroxisome \[[@B3-toxins-10-00270]\]. In this study, we not only observe down-regulation of these genes, but also identify the cellular pathways which may be affecting regulation of these genes and aflatoxin synthesis in general. We demonstrated that GA inhibited aflatoxin biosynthesis in *A. flavus* in a dose-dependent manner, where aflatoxin formation was partly inhibited by 0.2% (*w*/*v*) GA treatment and totally inhibited by more than 0.8% (*w*/*v*) GA treatment. To find out the genes mediating GA and aflatoxin biosynthesis in *A. flavus*, the transcriptomic profile of the 0, 0.2%, and 0.8% (*w*/*v*) GA-treated *A. flavus* samples was obtained based on the RNA-Seq technology. Taken together, the transcriptional profiling results suggested GA could be suppressing aflatoxin synthesis through several cellular pathways that have already been implicated in aflatoxin regulation: One inhibitory (pentose phosphate pathway) and two stimulatory routes (FarB mediated β-oxidation and CreA activity). The expression changes of those genes in 0.2% (*w*/*v*) GA treatment is consistent with the partly inhibited aflatoxin formation in this treatment. Both the pentose phosphate pathway and β-oxidation pathway are active in the peroxisome, the site of the initial steps of aflatoxin biosynthesis \[[@B3-toxins-10-00270]\]. Despite GA's role as an antioxidant, the RNA-seq and physiological testing ([Figure 6](#toxins-10-00270-f006){ref-type="fig"}) were less clear on the role of antioxidant pathways in suppressing aflatoxin synthesis, although potential involvement of the glutathione- and thioredoxin-dependent antioxidant systems will be a future avenue to address. We also note that the antioxidant activity of the gallic acid molecule itself could be a contributing factor \[[@B39-toxins-10-00270]\].

Aflatoxin molecular formation needs more than 23 enzymatic reactions \[[@B23-toxins-10-00270]\] and at least 10 NADPHs \[[@B40-toxins-10-00270]\], however, there is a competition for NADPH in acetyl-CoA incorporation into lipid synthesis, rather than into polyketides like aflatoxin \[[@B6-toxins-10-00270]\]. In the toxin-supporting medium (Glucose-mineral salts medium, GMS), diminished NADPH generating capacity indicated that depressed NADPH/NADP ratios favor aflatoxin biosynthesis \[[@B41-toxins-10-00270]\]. The two dehydrogenases (Zwf1 and Gnd1) in the oxidative branch of the pentose phosphate pathway, the main source of NADPH in the cell, are located in peroxisomes in *Candida albicans* \[[@B27-toxins-10-00270]\]. The genes AFLA_086620 and AFLA_036840, encoding the homologous Zwf1 and Gnd1 proteins, respectively, were upregulated by GA treatment ([Table 2](#toxins-10-00270-t002){ref-type="table"}), which indicated that GA treatment might regulate *A. flavus* intracellular NADPH pools and promote acyl-CoA incorporation into lipid synthesis, rather than polyketide production.

Acetyl-CoA is produced from the oxidative decarboxylation of pyruvate and fatty acid β-oxidation \[[@B40-toxins-10-00270]\], and fatty acid β-oxidation is a fundamental contributor to polyketide mycotoxin (aflatoxin and sterigmatocystin) formation \[[@B3-toxins-10-00270]\]. The fatty acid transcription factor FarB---which activates peroxisomal β-oxidation genes---has been shown to positively regulate aflatoxin production in *A. flavus* \[[@B17-toxins-10-00270]\]. In our RNA-Seq data, most of the genes involved in fatty acid β-oxidation, including *farB*, were downregulated by GA treatment ([Table S5](#app1-toxins-10-00270){ref-type="app"}). The transcript of *farB*, *foxA* (encoding the peroxisomal β-oxidation multifunctional enzyme), and *acuJ* (encoding carnitine acetyltransferase), were significantly decreased in the 0.8% (*w*/*v*) GA-treated samples compared to the untreated samples ([Table 2](#toxins-10-00270-t002){ref-type="table"}). Suppression of the peroxisomal β-oxidation pathway genes by GA treatment would be expected to reduce acyl-CoA pools and inhibit aflatoxin formation through lack of precursors.

Aflatoxin biosynthesis is also closely associated with carbohydrate catabolism \[[@B41-toxins-10-00270]\]. For example, glucose, sucrose, and fructose induced aflatoxin formation, while peptone and lactose did not support aflatoxin production \[[@B28-toxins-10-00270],[@B42-toxins-10-00270]\]. Abdollahi et al. \[[@B28-toxins-10-00270]\] suggested that the aflatoxin formation induced by these carbon sources was as a feedback regulation of the elevated energy state which was caused by the utilization of a readily-metabolizable carbohydrate. Microorganisms prefer utilizing the most favored carbon source with the mechanism of carbon repression, and the transcription factor CreA is a well-known as carbon repression regulator in *Aspergillus* \[[@B31-toxins-10-00270]\]. In *Aspergillus nidulans*, CreA can regulate carbon utilization genes via directly binding to the consensus sequence 5′-SYGGRG-3′ in the promoter of these genes \[[@B32-toxins-10-00270]\], and is critical for normal growth on carbon, nitrogen, and lipid sources \[[@B43-toxins-10-00270]\]. The CreA consensus binding sites have been found in the promoter regions of 14 assigned aflatoxin genes ([Table 3](#toxins-10-00270-t003){ref-type="table"}), and the expression of almost all the aflatoxin genes (except the regulator genes *aflR* and *aflS*) and the *creA* gene, AFLA_134680, were significantly suppressed by the 0.8% (*w*/*v*) GA treatment ([Figure 4](#toxins-10-00270-f004){ref-type="fig"}, [Table 2](#toxins-10-00270-t002){ref-type="table"}). To confirm the hypothesis that CreA was involved in aflatoxin gene regulation, we deleted *creA* in *A. flavus* and the ∆*creA* mutants were unable to produce the mycotoxin. The qRT-PCR result showed that the expression of the aflatoxin genes were significantly down regulated in the ∆*creA* mutants compared to WT, which is consistent with an identical role for this protein in aflatoxin biosynthesis in another strain of *A. flavus*, CA14 \[[@B18-toxins-10-00270]\]. Whether the regulation is direct via CreA binding of individual *afl* genes or indirect is still to be determined. In *A. flavus*, GprC was considered as a carbon sensing receptor \[[@B38-toxins-10-00270]\] which may mediate the expression of carbon utilization genes. As the GprC encoding gene was significantly inhibited by 0.8% (*w*/*v*) GA treatment, we propose that GA may depress *creA* expression through GprC signaling. Taking these results together, we suggest that GA inhibits aflatoxin biosynthesis in *A. flavus* via modulating the expression of the FarB and CreA pathways, a hypothetical mechanism proposed in [Figure 7](#toxins-10-00270-f007){ref-type="fig"}.

4. Materials and Methods {#sec4-toxins-10-00270}
========================

4.1. Fungal Strain and Culture Conditions {#sec4dot1-toxins-10-00270}
-----------------------------------------

*Aspergillus flavus* NRRL3357 \[[@B44-toxins-10-00270]\], TJES20.1 (∆*ku70*, ∆*argB*::*A. fumigatus pyrG*, *pyrG*-) \[[@B45-toxins-10-00270]\], and TJW149.27 (∆*ku70*::*A. parasiticus pyrG*, *pyrG*-) were used in this research. A total of 10^7^ *A. flavus NRRL3357* spores were inoculated into 30 mL PDB (BD Difco) with different concentrations (0, 0.2%, 0.5%, 0.8%, and 1% *w*/*v*) of GA, cultured at 30 °C, 200 rpm for aflatoxin analysis or mycelia weight measurement. A total of 10^3^ spores were inoculated on PDA (BD Difco) medium with different concentrations (*w*/*v*) of GA and cultured at 30 °C for diameter determination. TJES20.1 was used for deleting *creA* gene in *A. flavus*, and TJW149.27 was used as control for *creA* mutants.

4.2. Aflatoxin Analysis and Measuring the A. flavus Colony Diameters and Mycelia Weights {#sec4dot2-toxins-10-00270}
----------------------------------------------------------------------------------------

Aflatoxin was extracted from 200 µL culture medium and analyzed by modified thin-layer chromatography (TLC) \[[@B46-toxins-10-00270]\]. A total of 10^3^ *A. flavus* spores were point-inoculated on PDA medium with different concentrations of GA, the plates were cultured at 30 °C incubator, and the diameters were measured on different culture days. To investigate the effect of GA on *A. flavus* mycelia growth, 10^7^ *A. flavus* spores were inoculated into 30 mL PDB medium with or without 1% (*w*/*v*) GA, and cultured at 30 °C, 200 rpm. The mycelia were collected by using vacuum filtration and measured by analytical balance (0.0001 g) after drying in the oven.

4.3. RNA Extraction and cDNA Library Preparation for RNA-Seq Analysis {#sec4dot3-toxins-10-00270}
---------------------------------------------------------------------

Triplicate cultures of 10^7^ *A. flavus* spores were grown in PDB medium with 0, 0.2%, and 0.8% (*w*/*v*) GA, respectively, at 30 °C, 200 rpm, harvested after 24 h, and ground in a mortar and pestle under liquid nitrogen. TRIzol reagent (Invitrogen, Carlsbad, CA, USA) was used to extract total RNA from ground mycelia, according to the manufacturer's instructions. Library construction and RNA quality analysis for all nine samples were conducted by Annoroad (Beijing, China). The Agilent 2100 bioanalyzer with Agilent RNA 6000 Nano Kit (Agilent Technologies, Santa Clara, CA, USA) was used to assess the integrity and purity of the RNA samples. All samples had an RNA Integrity Number (RIN) with more than 8.0. The cDNA library construction was conducted as follows: The mRNA was purified by using Oligo (dT)-attached magnetic beads and fragmented into small pieces by Fragmentation Buffer. The fragmented mRNA was copied into first strand cDNA using random hexamer primers, then the dNTPs, RNase H, and DNA polymerase I were added into the reactions to get the second strand cDNA. These cDNA fragments were purified with QIAQuick PCR kit and eluted with elution buffer, then these cDNA fragments were treated through an end repair process, an addition of a single 'A' base, and then ligation of the sequencing adapters. Finally, the cDNA library was sequenced on the Illumina HiSeq platform.

4.4. Data Analysis and Normalizing the Expression Levels of Genes {#sec4dot4-toxins-10-00270}
-----------------------------------------------------------------

After removing the reads adapters, low quality reads, and reads with more than 5% N, the remaining reads were mapped to the *A. flavus* NRRL3357 genome (<https://www.ncbi.nlm.nih.gov/nuccore/AAIH00000000.2>) by using TopHat v2.0.12 \[[@B47-toxins-10-00270]\] and Bowtie2 \[[@B48-toxins-10-00270]\] software. The Fragments per Kilobase per Million Mapped Fragments (FPKM) \[[@B19-toxins-10-00270]\] was used to normalize the expression levels of the genes in these sequenced samples. The mean value of the count number of each gene from the three sequenced samples were analyzed by DEseq software \[[@B20-toxins-10-00270]\] for genes' different expression analysis, the genes from each compared sample with \|log2Ratio\| ≥ 1 and *q* \< 0.05 were considered as significantly differentially expressed between these compared samples. GO analysis was done by Blast2GO software. The transcriptomic profile of the detectable genes in this research can be found in [Table S3](#app1-toxins-10-00270){ref-type="app"}.

4.5. creA Mutant Construction and qRT-PCR Analysis
--------------------------------------------------

All primers used for *creA* mutant construction are listed in [Table S7](#app1-toxins-10-00270){ref-type="app"}. The homologous recombination technology was used to create a *creA* mutant \[[@B45-toxins-10-00270]\]. All PCR-generated flanks ranged in size around 1.5 kb, *argB* with its own promotor and terminator from *A. flavus* and wild type genomic DNA was used as the marker gene. The transformation construct for *creA* mutant was made by double joint PCR \[[@B49-toxins-10-00270]\] and transformed into the parental strain TJES20.1 (∆*ku70*, ∆*argB*::*Aspergillus fumigatus pyrG*, *pyrG*-). Transformation of fungal strains was carried out according to the protocol of Szewczyk et al. \[[@B50-toxins-10-00270]\], with some modifications that can be found in Zhao et al. \[[@B51-toxins-10-00270]\]. The *creA* mutants were confirmed by PCR and qRT-PCR ([Figure S1A,B](#app1-toxins-10-00270){ref-type="app"}), and aflatoxin synthesis of *creA* mutants ([Figure S1C](#app1-toxins-10-00270){ref-type="app"}) was analyzed by TLC, the primers for qRT-PCR can be found in [Table S7](#app1-toxins-10-00270){ref-type="app"}. A total of 10^7^ spores of WT, ∆*creA*-1, and ∆*creA*-2 were inoculated into 30 mL PDB medium, and cultured at 200 rpm, 30 °C for 3 days, and the mycelia were collected for RNA extraction. RNA was extracted by Trizol (Invitrogen, Carlsbad, CA, USA) following the manufacturer's instructions. RNA quality and quantity were measured by NanoVue plus (GE Healthcare, Buckinghamshire, UK). Reverse transcription was carried out by HiScriptIIQ RT SuperMix (Vazyme, Nanjing, China) for qRT-PCR.

4.6. Antioxidant Enzymatic Activities and the Lipid Oxidation Level Measurement {#sec4dot6-toxins-10-00270}
-------------------------------------------------------------------------------

In order to observe the impact of GA on the antioxidant system activities in *A. flavus*, superoxide dismutase (SOD), catalase (CAT), and the content of Malondialdehyde (MDA) were performed on 24 h cultures, following the same culture conditions of RNA isolation.

Around 300 mg mycelium were suspended in 800 µL PBS buffer and homogenized by Tissuelyser^®^ (Jingxin industrial development Co., Shanghai, China). Then samples were centrifuged at 12,000 rpm for 10 min at 4 °C, the supernatants were used for measuring the enzymes activities, MDA content, and protein concentrations. The catalase assay kit (S0051) and total superoxide dismutase assay kit with WST-8 (S0101) were used to measure the enzymes activities, the MDA content was determined using lipid peroxidation MDA assay kit (S0131), and protein concentrations were measured using an enhanced BCA protein assay kit (P0010). All these measurements were conducted according to manufacturer's instructions, and these kits were bought from Beyotime Biotechnology (Beijing, China). The enzymatic activities and MDA content were normalized according to their protein concentrations.

4.7. Statistical Analysis {#sec4dot7-toxins-10-00270}
-------------------------

All the wet-lab experiments were conducted in triplicate. The GraphPad Prism software (La Jolla, CA, USA) was used for statistical analysis. Statistically significant differences were determined by an unpaired Student's *t*-test with a two-tailed distribution and *p* \< 0.05. The error bars in all figures indicate the standard error of the mean.
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![Gallic acid (GA) inhibits aflatoxin biosynthesis in *Aspergillus flavus* in a dose-dependent manner.](toxins-10-00270-g001){#toxins-10-00270-f001}

![GA affects *A. flavus* growth. (**A**) 10^3^ spores were inoculated on PDA medium with different concentrations (*w*/*v*) of GA and cultured at 30 °C, the diameters were measured on different culture days. (**B**) The photo of the samples on the 7th day cultivation. (**C**) 10^7^ spores were inoculated into 30 mL PDB with or without 1% (*w*/*v*) GA and cultured at 200 rpm, 30 °C for different days, then the mycelia were collected and measured. Each treatment has three replicates, \*: *p* \< 0.05, \*\*: *p* \< 0.01, \*\*\*: *p* \< 0.001.](toxins-10-00270-g002){#toxins-10-00270-f002}

![Venn diagram of the significantly differentially expressed genes. In total, 361 genes were shared in these two sets, of which 185 were upregulated. P02_P: Significantly differentially expressed genes between 0.2% (*w*/*v*) gallic acid-treated and untreated *A. flavus* samples. P08_P: Significantly differentially expressed genes between 0.8% (*w*/*v*) gallic acid-treated and untreated *A. flavus* samples.](toxins-10-00270-g003){#toxins-10-00270-f003}

![Effect of GA on the expression of the aflatoxin assigned genes in *A. flavus*. P: Untreated *A. flavus* samples, P02: 0.2% (*w*/*v*) GA treated *A. flavus* samples, P08: 0.8% (*w*/*v*) GA treated *A. flavus* samples. P02_P Ratio: The mean value of the count number of each gene in P02/in P. P08_P Ratio: The mean value of the count number of each gene in P08/in P.](toxins-10-00270-g004){#toxins-10-00270-f004}

![Expression ratios of the aflatoxin biosynthesis-assigned genes in the ∆*creA* mutants compared to wild type WT(TJW149.27). A total of 10^7^ spores of WT, ∆*creA*-1, and ∆*creA*-2 were inoculated into 30 mL PDB medium, and cultured at 200 rpm, 30 °C for 3 days, the mycelia was collected for RNA extraction, then the RNA was reverse transcript into cDNA for qRT-PCR analysis. The primers for the qRT-PCR can be found in [Table S7](#app1-toxins-10-00270){ref-type="app"}. The expression of each gene in the WT was normalized as 1.0, each sample has three replicates, and the error bars indicate the standard error of the mean.](toxins-10-00270-g005){#toxins-10-00270-f005}

![Effect of GA on lipid oxidant (**A**) and antioxidant enzymes activities (**B**,**C**) in *A. flavus*. P: Untreated *A. flavus* samples, P02: 0.2% (*w*/*v*) GA-treated *A. flavus* samples, P08: 0.8% (*w*/*v*) GA-treated *A. flavus* samples. \*\*: *p* \< 0.01, \*\*\*: *p* \< 0.001. MDA = Malondialdehyde, SOD = super oxide dismutase.](toxins-10-00270-g006){#toxins-10-00270-f006}

![Hypothetical mechanism of gallic acid (GA) inhibition of aflatoxin biosynthesis in *A. flavus*. GA inhibits (i) the expression of *creA*, which leads to the downregulation of the aflatoxin (AF) cluster genes, simultaneously GA (ii) reduces the peroxisomal fatty acids β-oxidation level by diminishing the expression of *farB*, resulting in decreasing the aflatoxin precursor acyl-CoA pools, and (iii) increasing the NADPH level via the pentose phosphate pathway, which favors lipid synthesis over aflatoxin biosynthesis in *A. flavus*. PM: Plasma membrane. The orange downward arrows indicate the expression of the genes that were significantly downregulated by GA treatment, the yellow upward arrows indicate the higher activity of the pentose phosphate pathway, which leads to increasing NADPH pools. Dotted lines indicate possible connecting pathways and solid lines indicate known pathways.](toxins-10-00270-g007){#toxins-10-00270-f007}

toxins-10-00270-t001_Table 1

###### 

Summary of the significantly differentially expressed genes among the three samples.

  Sample Name   P02_P   P08_P
  ------------- ------- -------
  Up            271     764
  Down          264     1276
  Total         535     2040

P02_P: 0.2% (*w*/*v*) GA treated samples (P02) compared with untreated samples (P), P08_P: 0.8% (*w*/*v*) GA treated samples (P08) compared with untreated samples (P). Up/Down: Genes' expression was significantly upregulated/downregulated in the samples before the dash, Total: All the significantly differentially expressed genes between the compared samples.

toxins-10-00270-t002_Table 2

###### 

Effect of gallic acid (GA) treatment on the expression of the transcription factor genes and primary metabolites related genes in *Aspergillus flavus.*

  -------------------------------------------------------------------------------------------
                  P02-P ^a^   P08-P ^b^                                                 
  --------------- ----------- ----------- ------ ----- --------- --------------- ------ -----
  *veA*\          −0.4470     0.6546      down   no    −0.3915   2.64 × 10^−1^   down   no
  (AFLA_066460)                                                                         

  *laeA*\         −0.2987     0.8134      down   no    −0.6969   1.71 × 10^−2^   down   no
  (AFLA_033290)                                                                         

  *velB*\         0.9331      0.1439      up     no    0.0635    9.35 × 10^−1^   up     no
  (AFLA_081490)                                                                         

  *brlA*\         −2.5580     0.0010      down   yes   −2.3343   9.88 × 10^−6^   down   yes
  (AFLA_082850)                                                                         

  *NsdC*\         1.6888      0.0091      up     yes   1.1464    3.45 × 10^−5^   up     yes
  (AFLA_131330)                                                                         

  *creA*\         −0.3367     0.8277      down   no    −1.1486   9.15 × 10^−8^   down   yes
  (AFLA_134680)                                                                         

  *farB*\         −0.7799     0.4354      down   no    −1.5190   4.81 × 10^−5^   down   yes
  (AFLA_012010)                                                                         

  *foxA*\         −0.5139     0.6420      down   no    −1.1589   1.71 × 10^−5^   down   yes
  (AFLA_041590)                                                                         

  *AcuJ*\         −0.8148     0.2928      down   no    −1.2998   1.85 × 10^−5^   down   yes
  (AFLA_135240)                                                                         

  *PexK*\         −0.7519     0.3792      down   no    −0.8524   2.72 × 10^−4^   down   no
  (AFLA_036410)                                                                         

  *zwf1*\         0.6412      0.4931      up     no    0.7590    6.7 × 10^−3^    up     no
  (AFLA_086620)                                                                         

  *sol3*\         0.2110      0.8837      up     no    1.0991    1.0 × 10^−4^    up     yes
  (AFLA_080390)                                                                         

  *gnd1*\         0.3718      0.7936      up     no    0.9072    1.3 × 10^−3^    up     no
  (AFLA_036840)                                                                         
  -------------------------------------------------------------------------------------------

^a^: 0.2% (*w*/*v*) GA-treated samples (P02) compared with the untreated samples (P). ^b^: 0.8% (*w*/*v*) GA-treated samples (P08) compared with the untreated samples (P). ^c^: The mean value of the count number of each gene in P02/in P. ^d^: The mean value of the count number of each gene in P08/in P. ^e^: The genes with \|Log2 ratio\| ≥ 1 and *p* value \< 0.05 were considered as significantly differentially expressed, described as 'yes', otherwise described as 'no'.

toxins-10-00270-t003_Table 3

###### 

Presence of the CreA consensus binding motif (5′-SYGGRG-3′) in the aflatoxin biosynthesis genes promotor region.

  --------------------------------------------------------------------------------------------------------------------------------------------
  Gene Name     CreA Binding Motif\    Position Relative to Start Codon   Description
                (5′-SYGGRG-3′) ^a^                                        
  ------------- ---------------------- ---------------------------------- --------------------------------------------------------------------
  AFLA_139190   GTGGAG                 −361                               *aflK*/*vbs*/VERB synthase

  AFLA_139200   CTGGAG                 −795                               *aflQ*/*ordA*/*ord*-1/oxidoreductase/cytochrome P450 monooxigenase

  AFLA_139210   No motif found                                            *aflP*/*omtA*/*omt*-1/*O*-methyltransferase A

  AFLA_139220   GTGGGG                 −1201                              *aflO*/*omtB*/*dmtA*/*O*-methyltransferase B

  AFLA_139230   CTGGGG/CCGGAG/GCGGAG   −355/−398/−301                     *aflI*/*avfA*/cytochrome P450 monooxygenase

  AFLA_139250   CTGGGG                 −238                               *aflL*/*verB*/desaturase/P450 monooxygenase

  AFLA_139260   CTGGGG/GCGGAG          −365/−810                          *aflG*/*avnA*/*ord*-1/cytochrome P450 monooxygenase

  AFLA_139280   No motif found                                            *aflN*/*verA*/monooxygenase

  AFLA_139300   No motif found                                            *aflM*/*ver*-1/dehydrogenase/ketoreductase

  AFLA_139310   CTGGGG/GCGGAG          −482/−617                          *aflE*/*norA*/*aad*/*adh*-2/NOR reductase/dehydrogenase

  AFLA_139320   CCGGGG/CTGGGG          −387/−299                          *aflJ*/*estA*/esterase

  AFLA_139330   GTGGGG/GCGGAG          −488/−58                           *aflH*/*adhA*/short chain alcohol dehydrogenase

  AFLA_139340   GTGGAG/CCGGGG          −737/−762                          *aflS*/pathway regulator

  AFLA_139360   GTGGGG/CCGGAG/CTGGAG   −369/−895/−276                     *aflR*/*apa*-2/*afl*-2/transcription activator

  AFLA_139370   CTGGAG/CTGGGG          −450/−819                          *aflB*/fas-1/fatty acid synthase beta subunit

  AFLA_139380   GTGGAG                 −116                               *aflA*/*fas*-2/*hexA*/fatty acid synthase alpha subunit

  AFLA_139390   No motif found                                            *aflD*/*nor*-1/reductase

  AFLA_139410   GTGGCG                 −763                               *aflC*/*pksA*/*pksL1*/polyketide synthase

  AFLA_139440   No motif found                                            *aflF*/*norB*/dehydrogenase
  --------------------------------------------------------------------------------------------------------------------------------------------

^a^: 5′-SYGGRG-3′, S: C + G, Y: C + T, R: A + G.

toxins-10-00270-t004_Table 4

###### 

Effect of GA on the expression of the antioxidant-related genes in *A. flavus*.

  ----------------------------------------------------------------------------------------------------------------------
                                            P02-P ^a^   P08-P ^b^                                                  
  ----------------------------------------- ----------- ----------- ------ ----- --------- ---------------- ------ -----
  *ppoC*\                                   −2.0268     0.0003      down   yes   −1.4056   7.25 × 10^−2^    down   no
  (AFLA_030430)                                                                                                    

  *gprC*\                                   −1.4207     0.0703      down   no    −1.5934   4.14 × 10^−6^    down   yes
  (AFLA_074150)                                                                                                    

  *gprK*\                                   −1.2764     0.3936      down   no    −2.1266   9.73 × 10^−4^    down   yes
  (AFLA_009790)                                                                                                    

  *gprM*\                                   −2.0079     0.0069      down   yes   −1.4338   3.74 × 10^−2^    down   yes
  (AFLA_075000)                                                                                                    

  glutathione S-transferase\                0.1570      0.9701      up     no    1.1480    1.20 × 10^−4^    up     yes
  (AFLA_016400)                                                                                                    

  glutathione S-transferase\                0.4667      0.6766      up     no    1.2355    2.13 × 10^−3^    up     yes
  (AFLA_023740)                                                                                                    

  glutathione S-transferase\                0.8037      0.3272      up     no    2.0188    1.07 × 10^−12^   up     yes
  (AFLA_087240)                                                                                                    

  AhpC/TSA family thioredoxin peroxidase\   1.1384      0.0655      up     no    1.2150    4.41 × 10^−5^    up     yes
  (AFLA_097940)                                                                                                    

  thioredoxin reductase Trr1/Trr2\          0.8950      0.2535      up     no    1.0196    3.79 × 10^−2^    up     yes
  (AFLA_051770)                                                                                                    
  ----------------------------------------------------------------------------------------------------------------------

^a^: 0.2% (*w*/*v*) GA-treated samples (P02) compared with the untreated samples (P). ^b^: 0.8% (*w*/*v*) GA-treated samples (P08) compared with the untreated samples (P). ^c^: The mean value of the count number of each gene in P02/in P. ^d^: The mean value of the count number of each gene in P08/in P. ^e^: The genes with \|Log2 ratio\| ≥ 1 and *p* value \< 0.05 were considered as significantly differentially expressed, described as 'yes', otherwise described as 'no'.

[^1]: These authors contributed equally to this work.
